Patents by Inventor Russell Baumann

Russell Baumann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oligonucleotides and methods for detecting hepatitis C viral nucleic acids
    Patent number: 7250506
    Abstract: The present invention provides methods and compositions for determining the presence and/or amount of HCV nucleic acids in a test sample. In particular, substantially purified oligonucleotide primers and probes are described that can be used for qualitatively and quantitatively detecting HCV nucleic acid in a test sample by amplification methods. The present invention also provides primers and probes for generating and detecting control nucleic acid sequences that provide a convenient method for assessing internal quality control of the HCV assay.
    Type: Grant
    Filed: January 16, 2004
    Date of Patent: July 31, 2007
    Assignee: Quest Diagnostics Investments Incorporated
    Inventors: Russell Baumann, Hasnah Hamdan, Michael Lewinski
  • Oligonucleotides and methods for detecting hepatitis C viral nucleic acids
    Publication number: 20060134632
    Abstract: The present invention provides methods and compositions for determining the presence and/or amount of HCV nucleic acids in a test sample. In particular, substantially purified oligonucleotide primers and probes are described that can be used for qualitatively and quantitatively detecting HCV nucleic acid in a test sample by amplification methods. The present invention also provides primers and probes for generating and detecting control nucleic acid sequences that provide a convenient method for assessing internal quality control of the HCV assay.
    Type: Application
    Filed: January 16, 2004
    Publication date: June 22, 2006
    Inventors: Russell Baumann, Hasnah Hamdan, Michael Lewinski
  • Oligonucleotides and methods for detecting hepatitis C viral nucleic acids
    Patent number: 6946245
    Abstract: The present invention provides methods and compositions for determining the presence and/or amount of HCV nucleic acids in a test sample. In particular, substantially purified oligonucleotide primers and probes are described that can be used for qualitatively and quantitatively detecting HCV nucleic acid in a test sample by amplification methods. The present invention also provides primers and probes for generating and detecting control nucleic acid sequences that provide a convenient method for assessing internal quality control of the HCV assay.
    Type: Grant
    Filed: December 4, 2001
    Date of Patent: September 20, 2005
    Assignee: Quest Diagnostics Investments Incorporated
    Inventors: Russell Baumann, Hasnah Hamdan, Michael Lewinski
  • Oligonucleotides and methods for detecting hepatitis C viral nucleic acids
    Publication number: 20050100889
    Abstract: The present invention provides methods and compositions for determining the presence and/or amount of HCV nucleic acids in a test sample. In particular, substantially purified oligonucleotide primers and probes are described that can be used for qualitatively and quantitatively detecting HCV nucleic acid in a test sample by amplification methods. The present invention also provides primers and probes for generating and detecting control nucleic acid sequences that provide a convenient method for assessing internal quality control of the HCV assay.
    Type: Application
    Filed: October 13, 2004
    Publication date: May 12, 2005
    Inventors: Russell Baumann, Hasnah Hamdan, Michael Lewinski
  • Oligonucleotides and methods for detecting hepatitis C viral nucleic acids
    Publication number: 20030104582
    Abstract: The present invention provides methods and compositions for determining the presence and/or amount of HCV nucleic acids in a test sample. In particular, substantially purified oligonucleotide primers and probes are described that can be used for qualitatively and quantitatively detecting HCV nucleic acid in a test sample by amplification methods. The present invention also provides primers and probes for generating and detecting control nucleic acid sequences that provide a convenient method for assessing internal quality control of the HCV assay.
    Type: Application
    Filed: December 4, 2001
    Publication date: June 5, 2003
    Inventors: Russell Baumann, Hasnah Hamdan, Michael Lewinski